Ubs Group Ag Pro Phase Labs, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 3,229 shares of PRPH stock, worth $1,711. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,229

Previous 10,508 69.27%

Holding current value

$1,711

Previous $25,000 92.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.61 - $2.47 $4,440 - $17,979	-7,279 Reduced 69.27%	3,229 $2,000
Q3 2024 Nov 14, 2024	BUY	$2.16 - $4.06 $22,697 - $42,662	10,508 New	10,508 $25,000
Q1 2024 May 13, 2024	BUY	$4.47 - $6.47 $14,853 - $21,499	3,323 New	3,323 $21,000
Q1 2023 May 12, 2023	SELL	$6.62 - $9.57 $78,069 - $112,859	-11,793 Reduced 71.3%	4,748 $36,000
Q4 2022 Feb 08, 2023	SELL	$8.78 - $12.47 $78,317 - $111,232	-8,920 Reduced 35.03%	16,541 $159,000
Q3 2022 Nov 10, 2022	BUY	$8.96 - $14.7 $215,255 - $353,152	24,024 Added 1671.82%	25,461 $287,000
Q2 2022 Aug 10, 2022	SELL	$6.52 - $13.24 $436 - $887	-67 Reduced 4.45%	1,437 $18,000
Q1 2022 May 16, 2022	SELL	$6.2 - $7.87 $2,256 - $2,864	-364 Reduced 19.49%	1,504 $11,000
Q4 2021 Feb 14, 2022	BUY	$5.13 - $7.89 $9,582 - $14,738	1,868 New	1,868 $13,000
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.82 $44,205 - $70,692	-9,040 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$4.61 - $6.83 $40,863 - $60,541	8,864 Added 5036.36%	9,040 $56,000
Q1 2021 May 12, 2021	SELL	$6.19 - $16.0 $5,849 - $15,120	-945 Reduced 84.3%	176 $1,000
Q4 2020 Feb 11, 2021	SELL	$3.9 - $11.25 $15,529 - $44,797	-3,982 Reduced 78.03%	1,121 $11,000
Q3 2020 Nov 12, 2020	SELL	$1.4 - $3.87 $2,550 - $7,051	-1,822 Reduced 26.31%	5,103 $18,000
Q2 2020 Jul 31, 2020	SELL	$1.2 - $1.99 $9,166 - $15,201	-7,639 Reduced 52.45%	6,925 $10,000
Q1 2020 May 01, 2020	BUY	$1.74 - $2.1 $1,900 - $2,293	1,092 Added 8.11%	14,564 $28,000
Q4 2019 Feb 14, 2020	BUY	$1.66 - $2.2 $224 - $297	135 Added 1.01%	13,472 $26,000
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.2 $5,766 - $7,783	-3,538 Reduced 20.97%	13,337 $26,000
Q2 2019 Aug 14, 2019	SELL	$2.1 - $3.07 $5,298 - $7,745	-2,523 Reduced 13.01%	16,875 $36,000
Q1 2019 May 14, 2019	SELL	$2.7 - $3.65 $8,756 - $11,836	-3,243 Reduced 14.32%	19,398 $58,000
Q4 2018 Feb 14, 2019	SELL	$2.95 - $3.27 $1,935 - $2,145	-656 Reduced 2.82%	22,641 $71,000
Q3 2018 Nov 14, 2018	SELL	$2.94 - $3.23 $7,103 - $7,803	-2,416 Reduced 9.4%	23,297 $70,000
Q2 2018 Aug 14, 2018	BUY	$2.84 - $5.41 $24,500 - $46,672	8,627 Added 50.49%	25,713 $84,000
Q1 2018 May 15, 2018	SELL	$2.24 - $3.21 $31 - $44	-14 Reduced 0.08%	17,086 $51,000
Q4 2017 Feb 14, 2018	SELL	$2.05 - $2.3 $10,239 - $11,488	-4,995 Reduced 22.61%	17,100 $37,000
Q3 2017 Nov 14, 2017	BUY	$2.03 - $2.29 $22,269 - $25,121	10,970 Added 98.61%	22,095 $48,000
Q2 2017 Aug 14, 2017	BUY	N/A	525 Added 4.95%	11,125 $23,000
Q1 2017 Nov 14, 2017	BUY	N/A	10,600	10,600 $24,000

Others Institutions Holding PRPH

# of Institutions

Shares Held

2.38M

Call Options Held

Put Options Held

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $8.49M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account